Baudax Bio Inc

NASDAQ:BXRX   3:53:58 PM EDT
0.27
0.00 (+0.45%)
Products

Baudax Bio Receives Notice Of Allowance For U.S. Patent Application Covering Use Of Anjeso For Treatment Of Moderate To Severe Pain

Published: 08/22/2022 12:20 GMT
Baudax Bio Inc (BXRX) - Baudax Bio Receives Notice of Allowance for U.S. Patent Application Covering Use of Anjeso® for Treatment of Moderate to Severe Pain.